Staphylococcal Scalded Skin Syndrome (SSSS) / (Ritter’s Disease) - Dermatology Notes

Definition: An exfoliative toxin-mediated dermatosis caused by Staphylococcus aureus (usually phage group II, strains 71 and 55), leading to superficial intraepidermal cleavage through desmoglein-1 disruption. Primarily affects infants and young children; in adults, associated with renal failure or immunosuppression.

Key Clinical Features:

• Prodrome: Fever, irritability, malaise.

• Cutaneous: Tender, widespread erythema (often starting periorally and intertriginous) followed by superficial, fragile bullae that rupture easily, leaving large, moist, erythematous denuded areas (scalded appearance).

• Nikolsky sign: Positive (gentle lateral pressure exfoliates skin).

• Mucous membranes: Spared (key distinguishing feature from toxic epidermal necrolysis).

• Healing: Rapid re-epithelialization (5–7 days) without scarring.

Associated Conditions/Diseases:

• Bullous impetigo (localized form of same toxin-mediated disease).

• Adult SSSS (rare; almost always with underlying renal insufficiency or immunocompromise).

Prognosis:

• Excellent in children (mortality <5% with treatment).

• Poor in adults (mortality 50–60%) due to underlying comorbidities.

Differential Diagnosis:

• Toxic epidermal necrolysis (TEN): Mucosal involvement, drug history, full-thickness necrosis, negative Nikolsky? No – Nikolsky positive in TEN too, but mucosal lesions, histology shows full-thickness epidermal necrosis.

• Kawasaki disease: No blistering or exfoliation.

• Scalding injury: History.

• Stevens-Johnson syndrome: Target lesions, mucosal involvement.

Management with Rationale:

1. IV antistaphylococcal antibiotic (e.g., flucloxacillin or cefazolin) → eliminates toxin-producing S. aureus.

2. Supportive care → fluid/electrolyte balance, temperature regulation (like burns).

3. Avoid corticosteroids → worsen infection.

4. Skin care → emollients, non-adherent dressings.

5. No surgical debridement → plane of cleavage is superficial (granular layer), heals spontaneously.

Histopathology

1. FOUNDATIONS (First Principles)

• Epidermis: Stratified squamous epithelium. Layers (base to surface): basal → spinous → granular → stratum corneum.

• Desmosomes: Intercellular junctions (cadherin family: desmoglein-1, desmoglein-3, desmocollins) providing mechanical adhesion.

• Desmoglein-1 (Dsg1): Predominant in superficial epidermis (granular layer); neutralized by exfoliative toxins.

• Desmoglein-3 (Dsg3): Predominant in deeper epidermis and mucous membranes; resistant to exfoliative toxin.

2. INITIATING EVENT

• Molecular: Exfoliative toxin A or B (ETA, ETB) – serine proteases produced by S. aureus at a distant site (e.g., nasopharynx, otitis media, conjunctivitis).

• Trigger: Toxin enters bloodstream → binds to skin.

3. PATHOGENESIS

• Toxin binds specifically to Dsg1 at the extracellular domain.

• Cleaves Dsg1 at a single site (between glutamic acid and serine) → conformational change.

• Desmosomes in the granular layer disassemble → loss of cell-cell adhesion.

• No inflammatory infiltrate because toxin is superantigen? No – actually minimal inflammation because cleavage is direct, not immune-mediated.

• Cleavage plane: intraepidermal at the granular layer (stratum granulosum).

• Deeper layers (stratum spinosum) have Dsg3 → remain intact.

• Mucous membranes express Dsg3 predominantly → spared.

4. HISTOPATHOLOGY

• Low power: Superficial perivascular sparse lymphohistiocytic infiltrate (minimal). Epidermis shows separation.

• High power: Intraepidermal cleavage at the granular layer – just below the stratum corneum.

• Key feature: Split is subcorneal (between stratum corneum and stratum granulosum).

• Why this appearance: Toxin cleaves Dsg1, which is most abundant in granular layer desmosomes. Corneodesmosomes (stratum corneum) are also affected but cleavage occurs at the weakest point – the granular layer interface.

• Cells involved: Keratinocytes in granular layer are rounded up, acantholytic? No – they are not acantholytic; they are separated but not rounded because toxin directly cleaves adhesion without causing cell shrinkage.

• No full-thickness necrosis (unlike TEN).

• No extensive neutrophilic infiltrate (unlike bullous impetigo where toxin is localized).

5. NAMING LOGIC & TERMINOLOGY

• "Scalded skin" – Clinical appearance mimics a scald burn.

• "Subcorneal" – Below the corneal layer (stratum corneum).

• "Intraepidermal" – Within the epidermis, not at dermo-epidermal junction.

• Not "acantholysis" in pemphigus sense – no rounded-up keratinocytes; just separation.

6. STAINING & MARKERS

• H&E: Shows subcorneal cleft. No eosinophils, no necrotic keratinocytes.

• Immunofluorescence (DIF): Negative (not autoimmune).

• Electron microscopy: Cleavage through desmosomes in granular layer; desmosomes appear intact but detached from keratinocyte membrane.

• Immunohistochemistry: Loss of Dsg1 staining in superficial epidermis (research, not diagnostic).

7. TEMPORAL EVOLUTION

• Early (erythema stage): Mild spongiosis, subtle subcorneal edema.

• Established (bullous stage): Clear subcorneal bulla, very few inflammatory cells.

• Late (desquamation stage): Re-epithelialization from stratum spinosum, no scarring. Histology shows mild acanthosis and parakeratosis.

8. PATTERN RECOGNITION & DIAGNOSTIC LOGIC

• Pattern: Subcorneal blister with minimal inflammation.

• Diagnostic pathway:

  • Subcorneal blister + no mucosal lesions + child + positive Nikolsky → SSSS.

  • Subcorneal blister + pustules + localized → bullous impetigo.

  • Full-thickness epidermal necrosis + mucosal lesions → TEN.

  • Subcorneal blister + eosinophils + spongiosis → pemphigus foliaceus (but DIF positive).

9. CLINICO-PATHOLOGICAL CORRELATION

• Nikolsky positive: Because cleavage is so superficial that gentle pressure shears off the entire stratum corneum.

• Tender erythema: Toxin-induced cytokine release (IL-1, IL-6).

• No scarring: Basal layer intact → regeneration from basal keratinocytes.

• Spared mucous membranes: Dsg3 protection.

10. EXAM-FOCUSED INSIGHTS

• Most common cause: S. aureus phage group II (types 71, 55).

• Most common age: Neonates and infants (<5 years) – immature renal clearance of toxin.

• Adult SSSS = renal failure until proven otherwise.

• Histology is diagnostic – subcorneal cleavage without acantholysis.

• Do NOT confuse with TEN – TEN shows full-thickness necrosis, mucosal involvement.

• Nikolsky sign – positive in both SSSS and TEN, so not helpful for differentiation.

• Treatment: Anti-staphylococcal antibiotics + supportive care. No steroids.

Must-Know Board Exam Questions & Answers

Q1: A 2-year-old presents with fever, diffuse tender erythema, and perioral crusting. Gentle lateral pressure on the skin causes exfoliation. Mucous membranes are normal. What is the most likely diagnosis?

A: Staphylococcal Scalded Skin Syndrome (SSSS).

Q2: What is the histological plane of cleavage in SSSS?

A: Subcorneal (intraepidermal at the granular layer).

Q3: Why are mucous membranes spared in SSSS?

A: Mucous membranes express desmoglein-3 (Dsg3), which is resistant to exfoliative toxin, whereas superficial epidermis expresses desmoglein-1 (Dsg1), which is cleaved by the toxin.

Q4: A 60-year-old with diabetes and chronic kidney disease develops generalized erythema and superficial desquamation. What must be considered?

A: Adult SSSS – always evaluate for underlying renal failure or immunosuppression.

Q5: What is the single most important histopathological feature differentiating SSSS from toxic epidermal necrolysis (TEN)?

A: SSSS shows subcorneal cleavage with minimal necrosis; TEN shows full-thickness epidermal necrosis.

Q6: Is direct immunofluorescence (DIF) positive or negative in SSSS?

A: Negative (SSSS is toxin-mediated, not autoimmune).

Q7: What is the mechanism of action of exfoliative toxin?

A: A serine protease that specifically cleaves desmoglein-1 at the granular layer desmosomes.

Q8: Why do children heal without scarring in SSSS?

A: The basal layer is intact; re-epithelialization occurs from viable basal keratinocytes.

Q9: What organism and phage group causes SSSS?

A: Staphylococcus aureus, phage group II (types 71 and 55).

Q10: Name two drugs that are contraindicated in SSSS.

A: Corticosteroids (worsen infection) and any ineffective antibiotic (e.g., vancomycin is not first-line unless MRSA suspected – but board answer often: steroids). More precisely: Corticosteroids are absolutely contraindicated.